Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells

Zhang,Yunjuan; Owusu,Lawrence; Duan,Wei; Jiang,Tao; Zang,Shizhu; Ahmed,Ayaz; Xin,Yi

doi:10.3892/ijmm.2013.1446

Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells

Authors:
- Yunjuan Zhang
- Lawrence Owusu
- Wei Duan
- Tao Jiang
- Shizhu Zang
- Ayaz Ahmed
- Yi Xin
View Affiliations

Affiliations: Department of Biotechnology, Dalian Medical University, Dalian, Liaoning, P.R. China, School of Medicine, Deakin University, Victoria, Australia
Published online on: July 16, 2013 https://doi.org/10.3892/ijmm.2013.1446
Pages: 959-964

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the third highest cause of cancer-related mortality in humans. Epigallocatechin-3-gallate (EGCG) has been shown to inhibit the metastatic activity of certain cancer cells. The aim of this study was to determine the effects and molecular mechanism(s) of action of EGCG in human HCC cells. A migration and invasion assay for the metastatic behavior of HCCLM6 cells was performed. The anti-metastatic effects of EGCG were investigated by RT-PCR and gelatin zymography. A total cellular protein profile was obtained using 2-dimensional gel electrophoresis (2-DE), followed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) analyses of proteins with significant differences in expression following treatment with EGCG. The results revealed that EGCG induced apoptosis and inhibited the metastasis of HCCLM6 cells. The anti-metastatic effects of EGCG were associated with the inhibition of matrix metalloproteinase (MMP)-2 and MMP-9 activity. The expression levels of far upstream element (FUSE) binding protein 1 (FUBP1), heat shock protein beta 1 (HSPB1), heat shock 60 kDa protein 1 (chaperonin) (CH60) and nucleophosmin (NPM) proteins, which are associated with metastasis, were significantly altered in the EGCG-treated HCCLM6 cells. The data from the present study suggest that EGCG has potential as a therapeutic agent for the treatment of HCC.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer. 94:153–156. 2001. View Article : Google Scholar : PubMed/NCBI
2	El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
3	Ikai I, Yamaoka Y, Yamamoto Y, et al: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg. 227:433–439. 1998. View Article : Google Scholar : PubMed/NCBI
4	Lee JS, Chu IS, Heo J, Calvisi DF, et al: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 40:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
5	Song HY, Liu YK, Feng JT, et al: Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol. 132:92–98. 2006. View Article : Google Scholar : PubMed/NCBI
6	Shukla Y: Tea and cancer chemoprevention: a comprehensive review. Asian Pacific J Cancer Prev. 8:155–165. 2007.PubMed/NCBI
7	Yang CS, Wang X, Lu G and Picinich SC: Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer. 9:429–439. 2009. View Article : Google Scholar : PubMed/NCBI
8	Yang CS and Wang ZY: Tea and cancer. J Natl Cancer Inst. 85:1038–1049. 1993. View Article : Google Scholar
9	Balentine DA, Wiseman SA and Bouwens LCM: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 37:693–704. 1997. View Article : Google Scholar : PubMed/NCBI
10	Mukhtar H and Ahmad N: Green tea in chemoprevention of cancer. Toxicol Sci. 52:111–117. 1999. View Article : Google Scholar : PubMed/NCBI
11	Singh BN, Shankar S and Srivastava RK: Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
12	Thawonsuwan J, Kiron V, Satoh S, et al: Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss. Fish Physiol Biochem. 36:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
13	Mukhtar H and Ahmad N: Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr. 71(Suppl 6): S1698–S1702. 2000.PubMed/NCBI
14	Thangapazham RL, Singh AK, Sharma A, et al: Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 245:232–241. 2007. View Article : Google Scholar : PubMed/NCBI
15	Shankar S, Ganapathy S, Hingorani SR and Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 13:440–452. 2008. View Article : Google Scholar : PubMed/NCBI
16	Stuart EC, Scandlyn MJ and Rosengren RJ: Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 79:2329–2336. 2006. View Article : Google Scholar : PubMed/NCBI
17	Sen T, Moulik S, Dutta A, et al: Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci. 84:194–204. 2009. View Article : Google Scholar : PubMed/NCBI
18	Lee SJ, Lee KW, Hur HJ, Chun JY, Kim SY and Lee HJ: Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells. Ann NY Acad Sci. 1095:536–544. 2007.PubMed/NCBI
19	Woodhouse EC, Chuaqui RF and Liotta LC: General mechanisms of metastasis. Cancer. 80(Suppl 8): S1529–S1537. 1997. View Article : Google Scholar
20	Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
21	Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M and Levens D: A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 8:465–480. 1994. View Article : Google Scholar
22	Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q and Chung MC: 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics. 8:5086–5096. 2008. View Article : Google Scholar
23	Sanz R, Aragüés R, Stresing V, Martín B, Landemaine T, Oliva B, et al: Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis. Clin Exp Metastasis. 24:673–683. 2007. View Article : Google Scholar : PubMed/NCBI
24	Hansen RK, Parra I, Hilsenbeck SG, Himelstein B and Fuqua SA: Hsp27-induced MMP-9 expression in influenced by the Src tyrosine protein kinase yes. Biochem Biophys Res Commun. 282:186–193. 2001. View Article : Google Scholar : PubMed/NCBI
25	Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, et al: Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer. 107:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
26	Sanna B, Debidda M, Pintus G, et al: The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway. Arch Biochem Biophys. 403:209–218. 2002. View Article : Google Scholar
27	Borer RA, Lehner CF, Eppenberger HM and Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 56:379–390. 1989. View Article : Google Scholar : PubMed/NCBI
28	Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, et al: Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol. 28:7050–7065. 2008. View Article : Google Scholar : PubMed/NCBI
29	Yung BY, Bor AM and Chan PK: Short exposure to actinomycin D induces ‘reversible’ translocation of protein B23 as well as ‘reversible’ inhibition of cell growth and RNA synthesis in HeLa cells. Cancer Res. 50:5987–5991. 1990.
30	Chan PK and Chan FY: A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin. Biochem Pharmacol. 57:1265–1273. 1999. View Article : Google Scholar : PubMed/NCBI
31	Herkert B, Dwertmann A, Herold S, Abed M, Naud JF, Finkernagel F, et al: The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol. 188:905–918. 2010. View Article : Google Scholar : PubMed/NCBI
32	Feng Y, Tian ZM, Wan MX and Zheng ZB: Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. World J Gastroenterol. 13:2608–2614. 2007. View Article : Google Scholar : PubMed/NCBI
33	Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, et al: Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics. 3:724–737. 2003. View Article : Google Scholar : PubMed/NCBI
34	Tsai YP, Yang MH, Huang CH, et al: Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis. 30:1049–1057. 2009. View Article : Google Scholar : PubMed/NCBI